---
$id: https://graph.org.ai/products/commodity/51313110
$type: Product
source: UNSPSC
code: "51313110"
title: "Buclizine hydrochloride"
class: "51313100"
classTitle: "Antihistamine or H1 blocker piperazines"
family: "51310000"
familyTitle: "Antihistamines or H1 blockers"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Buclizine hydrochloride

**UNSPSC Code**: 51313110
**Class**: [Antihistamine or H1 blocker piperazines](Antihistamine or H1 blocker piperazines.mdx)
**Family**: [Antihistamines or H1 blockers](../Antihistamines or H1 blockers.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C28H33ClN2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 58FQD093NU, chemically known as piperazine, 1-(p-tert-butylbenzyl)-4-(p-chloro-.alpha.-phenylbenzyl)-, dihydrochloride but more generally known as buclizine hydrochloride, which bears US NIH Compound Identifier 6729. European Medicines Agency schedules Buclizine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00889MIG. Most nations, for tariff and trade purposes, schedule buclizine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, BUCLIZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Buclizine hydrochloride bears US NLM identifiers UMLS ID C0304304 and NCI Concept Code C65274. SMILES: CC(C)(C)C1CCC(CC1)CN2CCN(CC2)C(C3CCCCC3)C4CCC(CC4)CL.CL.CL.

